Download 6.38 MB
Alzheimer s disease is hard to diagnose definitively because it relies on seeing particular pathology in the brain - a collection of a protein called amyloid and another called tau around the nerves. This makes it difficult to test treatments, and to predict the future for people with thinking and memory problems.
Guest:
Researchers demonstrate great potential for blood test to detect, monitor Alzheimer s disease
In three recent publications in
Brain and
JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for Alzheimer s disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials.
This is an extremely dynamic research field right now, thanks to the technological development and seminal scientific progress in the past years. The dream scenario is to have a blood test for the early detection and screening of Alzheimer s disease up and running. That would give significantly more people in the world access to testing and future treatments.
New studies support blood test for early detection of Alzheimer s disease
Molecular Psychiatry,
Brain and
JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for Alzheimer s disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials. This is an extremely dynamic research field right now, thanks to the technological development and seminal scientific progress in the past years. The dream scenario is to have a blood test for the early detection and screening of Alzheimer s disease up and running. That would give significantly more people in the world access to testing and future treatments , says Michael Schöll, associate professor and one of the senior authors.